BioSpace News Archive

Full year 2020 preliminary net revenues of $494.4 million, representing annual growth of 41 percent compared to 2019

Donanemab, an investigational antibody that targets a modified form of beta amyloid called N3pG, showed significant slowing of decline in a composite measure of cognition and daily function in patients with early symptomatic Alzheimer’s disease compared to placebo in results from Eli Lilly and Company’s (NYSE: LLY) Phase 2 TRAILBLAZER-ALZ study.

Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for individuals living with disabling hearing loss worldwide, and Blueprint Genetics, a Quest Diagnostics company, today announced the Resonate program.

Skylight Health Group Inc, one of the largest multi-specialty healthcare systems in the United States, announced that management will host virtual investor meetings during and after the virtual J.P. Morgan 39th Annual Healthcare Conference in January 2021.

Biogen Inc. (Nasdaq: BIIB) today announced a new virtual research study, in collaboration with Apple, to investigate the role Apple Watch and iPhone could play in monitoring cognitive performance and screening for decline in cognitive health including mild cognitive impairment (MCI).

Hearing loops, also called induction loops for audio frequency, provide a realistic and usually cost-effective solution to significantly enhance the signal-to-noise ratio and comprehension of speech.

Camphor is a transparent solid, odorous flammable compound. It is obtained essentially from the tree i.e. A tree known as the capur-tree found in Asia.

Smart inhalers are increasingly becoming the preferred course of managing and treating respiratory diseases.

Rising dependency of users on insecticide products in order to avoid the risk of insect-borne diseases is expected to propel the growth of the body worn insect repellent market in the future.

Eurofins GeneScan Technologies announces that the VIRSeek SARS-CoV-2 Solution has been evaluated and approved by the AOAC Performance Tested MethodsSM Program on December 29, 2020 and awarded Emergency Response Validation PTM certification number 122006.